Processa Pharmaceuticals(PCSA) - 2019 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] Annual Report under Section 13 or 15(d) of the Securities Exchange Act of 1934 7380 Coca Cola Drive, Suite 106, Hanover, Maryland 21076 (Address of principal executive offices) For the fiscal year ended December 31, 2019 or [ ] Transitional Report under Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 333-184948 Processa Pharmaceuticals, Inc. (Exact name of registrant as specified in its c ...